美国大学生数学建模比赛的论文格式

Team#32150pageofContentsⅠIntroduction……………………………………………………………………….11.1ProblemBackground………………………………………………...11.2PreviousResearch…………………………………………………...21.3OurWork………………………………………………………….....2ⅡGeneralAssumptions.............................................................................................3ⅢNotationsandSymbolDescription……………………………………………..33.1Notations…………………………………………………………….43.2SymbolDescription………………………………………………….4ⅣSpreadofEbola………………………………………………………………….54.1TraditionalEpidemicModel…………………………………………54.1.1.TheSEIRModel……………………………………………………..54.1.2………………………………………………………………………..64.1.3………………………………………………………………………..64.2ImprovedModel……………………………………………………..74.2.1.TheSEIHCRModel…………………………………………………84.2.2………………………………………………………………………..9ⅤPharmaceuticalIntervention……………………………………………………95.1TotalQuantityoftheMedicine…………………………………….105.1.1.ResultsfromWHOStatistics………………………………………105.1.2.ResultsfromSEIHCRModel……………………………………....115.2DeliverySystem……………………………………………………125.2.1.LocationsofDelivery………………………………………………135.2.2………………………………………………………………………145.3SpeedofManufacturing……………………………………………15ⅥOtherImportantInterventions.........................................................................166.1SaferTreatmentofCorpses………………………………………...176.2Conclusion………………………………………………………….18ⅦControlandEradicationofEbola…………………………………………….197.1HowEbolaCanBeControlled……………………………………..207.2WhenEbolaWillBeEradicated……………………………………21ⅧSensitivityAnalysis……………………………………………………………228.1ImpactofTransmissionRate……………………………………….238.2ImpactoftheIncubationPriod……………………………………..24Team#32150pageofⅨStrengthsandWeaknesses…………………………………………………….259.1Strengths…………………………………………………………..269.2Weaknesses………………………………………………………..279.3FutureWork……………………………………………………….28LettertotheWorldMedicalAssociation………………………………………......30References…………………………………………………………………………...31ⅠIntroduction1.1.PromblemBackground1.2.PreviousResearch1.3.OurWorkⅡGeneralAssumptionsTeam#32150pageofⅢNotationsandSymbolDescription3.1.Notataions3.2.SymbolDescriptionSymbolDescriptionⅣSpreadofEbola4.1.TraditionalEpidemicModel4.1.1.TheSEIRModelTeam#32150pageof4.1.2.OutbreakData4.1.3.ResltsoftheSEIRModel4.2.ImprovedModel4.2.1.TheSEIHCRModel4.2.2.ChoosingpaametersⅤPharmaceuticalIntervention5.1.TotalQuantityoftheMedicine5.1.1.ResultsfromWHOStatisticsTeam#32150pageof5.2.DeliverySystem5.2.1.LocationsofDelivery5.2.2.AmountofDelivery5.3.SpeedofManufacturong5.4.MedicineEfficacyⅥOtherImportantInterventions6.1.SaferTreatmentofCorpsesTeam#32150pageof6.2.ConclusionⅦControlandEradicationofEbola7.1.HowEbolaCanBeControlled7.2.WhenEbolaWillBeEradicatedⅧSensitivityAnalysis8.1.ImpactofTransmissionRate8.2.ImpactofIncubationPeriodTeam#32150pageofⅨStrengthsandWeaknesses9.1.Strengths9.2.Weaknesses9.3.FutureWorkTeam#32150pageofLettertotheWorldMedicalAssociationTowhomitmayconcern,Bestregards,Team#32150Team#32150pageofReferences［1］［2］［3］［4］